Results 181 to 190 of about 29,830 (263)
Romosozumab for the treatment of thalassemia-associated osteoporosis in two female patients. [PDF]
Yavropoulou MP +7 more
europepmc +1 more source
Graphical summary of the effects of additional intake of animal and plant proteins on anthropometric and body composition parameters in pre‐ and postmenopausal women. The arrows indicate an increase, decrease, or no significant effect. ABSTRACT This systematic review investigated the effect of protein intake on anthropometric and body composition ...
Sthéfany Nonato Fialho +4 more
wiley +1 more source
Bioinorganic hybrids show promise for solar‐to‐chemical conversion, yet are limited by poor light absorption and charge separation. A plasmonic biohybrid (CuS/CdS@yeast), featuring an intracellular S‐scheme heterojunction to achieve efficient electron‐hole separation, is fabricated via in‐situ mineralization for wide‐spectrum solar‐to‐chemical ...
Heng Yu +9 more
wiley +1 more source
Approach to osteoporosis diagnosis and fracture risk management in primary care. [PDF]
Garg D +5 more
europepmc +1 more source
Conceptual Framework: Livelihood, diet, and hair isotope values. ABSTRACT Objectives Rural populations in northern Laos have experienced dramatic socioeconomic transformation driven by national policies and regional economic integration, substantially influencing their self‐sufficient livelihoods.
Ziyang Li +13 more
wiley +1 more source
Combined physical and pharmacological anabolic osteoporosis therapies increase bone response and mechanoregulation in female mice. [PDF]
Schulte FA +10 more
europepmc +1 more source
Deep Mutational Scanning for the Study and Engineering of Protein Assemblies
This review explores how deep mutational scanning (DMS) can be used to improve understanding and accelerate engineering of protein assemblies, from natural fibers to engineered nanocages. We discuss various types of protein assemblies and their characterization, provide an introduction to the DMS technique, and then highlight examples in which DMS has ...
Jenna B. Wolfanger +2 more
wiley +1 more source
Management of male osteoporosis in primary care: clinical approach and pharmacotherapy. [PDF]
Poh SXJ, Choong SD, Gani LU, Chua ALA.
europepmc +1 more source
Discontinuing Long‐Term Denosumab in Treating Fragile Bone: Why, for Whom, and How?
Discontinuation of denosumab (Dmab) may be necessary due to adverse events or an unfavorable long‐term risk–benefit profile. However, accumulating evidence demonstrates pronounced rebound phenomena after withdrawal, most notably a marked increase in multiple vertebral fractures, and, in some reports, elevated mortality.
Ko‐Hsiu Lu +5 more
wiley +1 more source
G protein-coupled receptor signaling in osteogenic bone mesenchymal stem/stromal cells. [PDF]
Wolfe TJ, Weaver SR.
europepmc +1 more source

